Performance of two commercially available sequence-based HIV-1 genotyping systems for the detection of drug resistance against HIV type 1 group M subtypes.
The use of genotyping assays for the detection and evaluation of drug resistance mutations within the polymerase gene of human immunodeficiency virus type 1 (HIV-1) is becoming increasingly relevant in the clinical management of HIV-1 infection. However, genotypic resistance assays available current...
Autors principals: | Beddows, S, Galpin, S, Kazmi, S, Ashraf, A, Johargy, A, Frater, A, White, N, Braganza, R, Clarke, J, McClure, M, Weber, J |
---|---|
Format: | Journal article |
Idioma: | English |
Publicat: |
2003
|
Ítems similars
-
Simple detection of point mutations associated with HIV-1 drug resistance.
per: Frater, A, et al.
Publicat: (2001) -
Impact of baseline polymorphisms in RT and protease on outcome of highly active antiretroviral therapy in HIV-1-infected African patients.
per: Frater, A, et al.
Publicat: (2001) -
HIV-1 resistance genotyping by sequencing produces inconsistent results for mixed viral populations.
per: Frater, A, et al.
Publicat: (2000) -
Comparative response of African HIV-1-infected individuals to highly active antiretroviral therapy.
per: Frater, A, et al.
Publicat: (2002) -
The impact of HIV-1 subtype on the clinical response on HAART.
per: Frater, J
Publicat: (2002)